ME/CFS Updates: Potential new Biomarker – Apr 2019

Has Stanford found something in our blood? And can this be replicated?

View this post on Instagram

We're excited to announce a new OMF-funded research publication: A Nanoelectronics-blood-based diagnostic biomarker for ME/CFS A paper describing the nanoneedle was published in the Proceedings of the National Academy of Sciences. Ronald W. Davis, Ph.D. is the senior author. Rahim Esfandyarpour, Ph.D. is the lead author. The nanoneedle is a test that measures changes in immune cells with their blood plasma as a result of salt stress. Inside the nanoneedle, the immune cells interfere with a small electric current. The change in electrical activity is directly correlated with the health of the sample. The test, which is still in a pilot phase, is based on how a person’s immune cells respond to stress. With blood samples from 40 people — 20 with ME/CFS and 20 without — the test yielded precise results, accurately flagging all patients and none of the healthy individuals. Click the link in our bio to read more on our website and watch a video of Dr. Ron Davis explaining the new publication. You can also copy and paste this link to get there: #EndMECFS #MECFS #PwME #MyalgicE #OMF #OpenMedicineFoundation #millionsmissing #myalgicencephalomyelitis #Nanoneedle #Ron Davis #StanfordUniversity #StanfordMedicine

A post shared by Open Medicine Foundation (@openmedf) on

Tagged: Tags:

Leave A Comment?

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.